Drug information provided by: Merative, Micromedex®
Benralizumab injection is used together with other medicines to treat severe asthma in patients whose asthma is not controlled with their current asthma medicines. This medicine helps prevent severe asthma attacks (exacerbations) and can improve your breathing. It is also used in patients whose asthma has an eosinophilic phenotype. This medicine will not relieve an asthma attack that has already started.
Benralizumab helps reduce blood eosinophils, which are a type of white blood cell that may contribute to your asthma.
This medicine is available only with your doctor's prescription.
This product is available in the following dosage forms:
Portions of this document last updated: May 01, 2024
Copyright: © Merative US L.P. 1973, 2024. All rights reserved. Information is for End User's use only and may not be sold, redistributed or otherwise used for commercial purposes.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.